Towards Healthcare Research & Consulting

Breast Biopsy Devices Manufacturers Technological Advancements

Date : 08 April 2026

Companies Offerings in the Breast Biopsy Devices Market

Breast Biopsy Devices Market Companies are Hologic, Inc., Becton, Dickinson and Company (BD), Danaher Corporation (Leica Biosystems), Devicor Medical Products, Inc., Merit Medical Systems

Turn complex Breast Biopsy Devices Market data into clear, confident decisions - Download for Free.

Company Description
Hologic, Inc. Their portfolio offers products from advanced vacuum-assisted systems and imaging guidance platforms to site markers & specimen radiography.
Becton, Dickinson and Company (BD) It has explored diverse solutions for minimally invasive tissue collection & removal, like BD, EleVation, etc.
Danaher Corporation (Leica Biosystems) Their offerings focus on a full biopsy-to-diagnosis workflow, such as tissue markers & advanced AI-powered diagnostics.
Devicor Medical Products, Inc. A firm facilitates Mammotome Revolve, Mammotome Elite, Mammotome ST, MR, EX, etc.
Merit Medical Systems This offers Pink Achieve automatic device, CorVocet system, & TEMNO Elite system.
GE HealthCare Its offerings include Serena Bright Contrast-Enhanced Biopsy, Pristina Serena Biopsy System, etc.
Cook Medical This company provides diverse breast biopsy & localization devices.
Trivitron Healthcare They usually offer the MultiCare Platinum Prone Breast Biopsy Table for high-quality imaging & precision targeting.
Siemens Healthineers This prominently facilitates a complete set of breast biopsy solutions integrated directly into their mammography & MRI platforms. 
Fujifilm Healthcare Its offerings cover integrated or optional accessories for their advanced digital mammography systems.

What are the Latest Developments in the Breast Biopsy Devices Market?

  • In February 2026, Mammotome launched the Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy System.
  • In January 2026, iSono Health commercially launched ATUSA, an FDA-cleared, wearable & automated 3D quantitative breast ultrasound platform.
  • In July 2025, SimonMed Imaging unveiled Mammogram+ and Mammogram+ Heart, two new AI-powered mammogram services focused on enhancing early detection & advancing preventative care in breast & heart issues.

Breast Biopsy Devices Market- Supply China Analysis

R&D

  • Leaders are implementing identification of clinical needs, designing & engineering, then preclinical testing and validation solutions
  • Key Players: Hologic, Inc., Devicor Medical Products, Inc., Becton, Dickinson and Company (BD), etc.

 Clinical Trials & Regulatory Approvals

  • This majorly focuses on studying safety, efficacy, and ease of use as compared to existing gold standard techniques, with subsequent 510(k) clearance, coupled with a Premarket Approval (PMA). 
  • Key Players: Mayo Clinic, University of California, San Diego, AURA Health Technologies, etc.

Patient Support & Services

  • A key aim includes patient comfort, safety, & convenience, typically facilitating minimally invasive alternatives to surgical biopsies in outpatient settings.
  • Key Players: GE HealthCare, Merit Medical Systems, Inc., Siemens Healthineers, etc.

Market Trends

The global breast biopsy devices market size was estimated at USD 6.52 billion in 2025 and is predicted to increase from USD 7.03 billion in 2026 to approximately USD 13.82 billion by 2035, expanding at a CAGR of 7.8% from 2026 to 2035. The overall market progression is propelled by the massive burden of breast cancer cases, widespread demand for minimally invasive procedures, & continuous breakthroughs in AI-powered solutions. Additionally, giant firms are developing portable, wireless localization & robot-assisted systems.

Breast Biopsy Devices Market Size is USD 7.03 Billion in 2026.